Last reviewed · How we verify
Tobacco cessation pharmacotherapy
Tobacco cessation pharmacotherapy is a Small molecule drug developed by Iowa City Veterans Affairs Medical Center. It is currently in Phase 2 development.
At a glance
| Generic name | Tobacco cessation pharmacotherapy |
|---|---|
| Sponsor | Iowa City Veterans Affairs Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community (NA)
- Exenatide for Smoking Cessation and Prevention of Weight Gain (PHASE2)
- Smoking Cessation and Menstrual Cycle Phase (PHASE4)
- Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
- Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients (NA)
- Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment (PHASE4)
- A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse (NA)
- Mobile Contingency Management for Smoking Cessation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tobacco cessation pharmacotherapy CI brief — competitive landscape report
- Tobacco cessation pharmacotherapy updates RSS · CI watch RSS
- Iowa City Veterans Affairs Medical Center portfolio CI
Frequently asked questions about Tobacco cessation pharmacotherapy
What is Tobacco cessation pharmacotherapy?
Tobacco cessation pharmacotherapy is a Small molecule drug developed by Iowa City Veterans Affairs Medical Center.
Who makes Tobacco cessation pharmacotherapy?
Tobacco cessation pharmacotherapy is developed by Iowa City Veterans Affairs Medical Center (see full Iowa City Veterans Affairs Medical Center pipeline at /company/iowa-city-veterans-affairs-medical-center).
What development phase is Tobacco cessation pharmacotherapy in?
Tobacco cessation pharmacotherapy is in Phase 2.